Sprint Bioscience har tilldelats finansiering från VINNOVAs program Forska&Väx för att ta fram molekyler (läkemedelskandidater) som ska bli

Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company

Ranplan Group, -6,50%. Sprint Bioscience, -6,47%. Sprint Bioscience is part of the new Swedish pharmaceutical industry with a focus on innovation and development. At Sprint Bioscience, we develop small-molecule drug candidates - from idea to preclinical drug project - ready for licensing to the international pharma market. Visiting address. Novum Hälsovägen 7, Floor 8, Elevator A Huddinge Sweden.

Published. 13 Jul 2017 Sprint Bioscience is a pharmaceutical company focused on developing drugs to fight cancer. It runs pharmaceutical projects from conception to drug candidates View live SPRINT BIOSCIENCE AB chart to track its stock's price action. Find market predictions, SPRINT financials and market news.

Bolaget har en portfölj av läkemedelsprojekt som är inriktade på att angripa olika delar av cancercellers processer.

Senaste nyheter om - Sprint Bioscience, aktieanalys, kursutveckling och rapporter. Sprint Bioscience komplett bolagsfakta & börsnyheter från Analysguiden.

Author Homepage: hurra.se. Sprint Bioscience have established a fragment-based drug discovery (FBDD) platform with disciplines ranging from protein production, fragment screening, Andersson:Sprint Bioscience: Employment, Equity Ownership. Cantley:Petra Pharma: Equity Ownership. ResearchGate Logo.

Senaste nyheter om - Sprint Bioscience, aktieanalys, kursutveckling och rapporter. Sprint Bioscience komplett bolagsfakta & börsnyheter från Analysguiden.

MAX IV pairs up with Sprint Bioscience, a listed drug development company, in a new project to improve how companies can benefit from new, faster X-ray 5 dagar sedan Stockholmsbaserade Sprint Bioscience, som bedriver tidig preklinisk läkemedelsutveckling främst riktad mot cancer, meddelade under Jul 1, 2020 On July 1, 2020 Sprint Bioscience AB (publ) reported that Petra Pharma, in accordance with the opportunities provided by the parties' licensing 3 jun 2020 Intervju med Jessica Martinsson, vd för Sprint Bioscience som utvecklar läkemedelskandidater för att bekämpa cancer. Bolaget har en portfölj Feb 27, 2018 Sprint Bioscience AB, Novum, 14157 Huddinge, Sweden.

Aktieägarna i Sprint Bioscience AB (publ), org.nr 556789-7557 med säte i Stockholm, kallas härmed till årsstämma onsdagen den 13 maj 2020 kl. 16.00 på Novum, Hälsovägen 7, 141 57 Huddinge. Stock analysis for Sprint Bioscience AB (SPRINT:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company Jul 7, 2016 Under the agreement, Sprint Bioscience licenses a PIP4k2a inhibitor program targeting tumor metabolism to the Company. Subsequently, the Information on stock, financials, earnings, subsidiaries, investors, and executives for Sprint Bioscience. Use the PitchBook Platform to explore the full profile. Sprint Bioscience.
Stryka medhårs

Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression and purification, fragment screening, X-ray crystallography, and expansion of fragments into a patented lead series.

621 views621 views. • Oct 16, 2020. Like.
Periodisera intäkter enskild firma

SPRINT BIOSCIENCE: Två nya indikationer stärker VADA-projektets position. Vi fick en pratstund med Sprint Biosciences forskningschef Martin Andersson,

Sprint Bioscience is a complete pharmaceutical company focused on 2021-03-08 Senaste nyheter om - Sprint Bioscience, aktieanalys, kursutveckling och rapporter. Sprint Bioscience komplett bolagsfakta & börsnyheter från Analysguiden.